Intermittent megadose treatment with vitamin D3 is not optimal to keep serum 25OHD levels at or over the target of 75 nmol/L




Valimaki VV, Pekkarinen T, Loyttyniemi E, Valimaki M

PublisherSPRINGER LONDON LTD

2013

Osteoporosis International

OSTEOPOROSIS INTERNATIONAL

OSTEOPOROSIS INT

24

S43

S44

2

0937-941X




Last updated on 2024-26-11 at 23:23